Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Haycox

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Pain and Symptom Management|July 21, 2009
Optimizing decision making and resource allocation in palliative careAlan Haycox
Clinical Drug Investigation|May 26, 2007
Insulin aspart : an evidence-based medicine reviewAlan Haycox
Pharmacoeconomics|January 19, 2006
Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness modelsAlan Haycox
Journal of Medical Economics|May 20, 2009
Cost effectiveness of asthma treatment with a breath-actuated inhaler: how has the story changed?Alan Haycox, Richard Featherstone
Pharmacoeconomics|June 4, 2011
Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practiceMark Parker, Alan Haycox, Jane Graves
Vaccine|November 16, 2004
Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trialStephen Allsup, Alan Haycox, Martyn Regan, et al.
Drugs & Aging|September 5, 2009
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluationAlan Haycox, Christophe Armand, Susana Murteira, et al.
Pharmacoeconomics|August 15, 2014
Through a glass darkly: economics and personalised medicineAlan Haycox, Munir Pirmohamed, Claire McLeod, et al.
Pharmacoeconomics - Open|February 4, 2018
Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and ImplicationsArianit Jakupi, Brian Godman, Antony Martin, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2011
European countries with small populations can obtain low prices for drugs: Lithuania as a case historyKristina Garuoliene, Brian Godman, Jolanta Gulbinovič, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Pain and Symptom Management|July 21, 2009
Optimizing decision making and resource allocation in palliative careAlan Haycox
Clinical Drug Investigation|May 26, 2007
Insulin aspart : an evidence-based medicine reviewAlan Haycox
Pharmacoeconomics|January 19, 2006
Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness modelsAlan Haycox
Journal of Medical Economics|May 20, 2009
Cost effectiveness of asthma treatment with a breath-actuated inhaler: how has the story changed?Alan Haycox, Richard Featherstone
Pharmacoeconomics|June 4, 2011
Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practiceMark Parker, Alan Haycox, Jane Graves
Vaccine|November 16, 2004
Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trialStephen Allsup, Alan Haycox, Martyn Regan, et al.
Drugs & Aging|September 5, 2009
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluationAlan Haycox, Christophe Armand, Susana Murteira, et al.
Pharmacoeconomics|August 15, 2014
Through a glass darkly: economics and personalised medicineAlan Haycox, Munir Pirmohamed, Claire McLeod, et al.
Pharmacoeconomics - Open|February 4, 2018
Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and ImplicationsArianit Jakupi, Brian Godman, Antony Martin, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2011
European countries with small populations can obtain low prices for drugs: Lithuania as a case historyKristina Garuoliene, Brian Godman, Jolanta Gulbinovič, et al.
Pageof 5